Moreover, since CSF brevican and neurocan peptide levels were decreased in vascular dementia compared with healthy controls [30], and thus might serve as potential diagnostic biomarkers, the even lower levels of these peptides in iNPH without cardiovascular comorbidities, might reflect further, different pathological processes specific to iNPH. The gene discussed is BCAN; the disease is vascular dementia.